# Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes

> **NCT03297879** · PHASE4 · COMPLETED · sponsor: **Beijing Chao Yang Hospital** · enrollment: 230 (actual)

## Conditions studied

- Type2 Diabetes

## Interventions

- **DRUG:** Exenatide or metformin hydrochloride

## Key facts

- **NCT ID:** NCT03297879
- **Lead sponsor:** Beijing Chao Yang Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-01
- **Primary completion:** 2016-02-28
- **Final completion:** 2016-02-28
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2017-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03297879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03297879, "Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients With Newly Diagnosed Type 2 Diabetes". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03297879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*